中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2015年
17期
15-17,20
,共4页
药物%治疗%血小板减少
藥物%治療%血小闆減少
약물%치료%혈소판감소
Medication%Treatment%Thrombocytopenia
通过查阅近年文献，对国内外治疗化疗致血小板减少临床研究概况进行综述，结果表明，应用西药或中药进行治疗临床研究较多，中西药物联合应用文献较少。中西药联合应用治疗化疗过程中血小板减少症，具有安全、有效、疗效确切、不良反应少等特点，值得进一步开发研究。
通過查閱近年文獻，對國內外治療化療緻血小闆減少臨床研究概況進行綜述，結果錶明，應用西藥或中藥進行治療臨床研究較多，中西藥物聯閤應用文獻較少。中西藥聯閤應用治療化療過程中血小闆減少癥，具有安全、有效、療效確切、不良反應少等特點，值得進一步開髮研究。
통과사열근년문헌，대국내외치료화료치혈소판감소림상연구개황진행종술，결과표명，응용서약혹중약진행치료림상연구교다，중서약물연합응용문헌교소。중서약연합응용치료화료과정중혈소판감소증，구유안전、유효、료효학절、불량반응소등특점，치득진일보개발연구。
Through consulting the literature in recent years,and summary of the clinical research on the treatment of thrombocytopenia caused by chemotherapy in China and abroad,the results showed that the combination of Chinese and Western medicine have less literature,compared with the Western medicine or the traditional Chinese medicine for the treatment.The Chinese and Western medicines combined with chemotherapy in the treatment of thrombocytopenia,which is more effective,safer and lower adverse reaction rate.It is worthy of further research and development.
